ArticleOpen forum infectious diseases2022

Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19.

Sarah Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.